Stephen Baxter
Stock Analyst at Wells Fargo
(2.31)
# 2,635
Out of 4,900 analysts
182
Total ratings
41.74%
Success rate
-1.78%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Maintains: Overweight | $478 → $400 | $339.17 | +17.93% | 11 | Jul 15, 2025 | |
| OSCR Oscar Health | Downgrades: Underweight | $16 → $10 | $14.72 | -32.07% | 11 | Jul 11, 2025 | |
| PNTG The Pennant Group | Maintains: Equal-Weight | $30 → $31 | $24.05 | +28.90% | 1 | Jun 3, 2025 | |
| MCK McKesson | Maintains: Equal-Weight | $691 → $766 | $712.64 | +7.49% | 6 | Jun 3, 2025 | |
| COR Cencora | Upgrades: Overweight | $274 → $337 | $295.31 | +14.12% | 3 | Jun 3, 2025 | |
| CAH Cardinal Health | Upgrades: Overweight | $136 → $179 | $161.34 | +10.95% | 7 | Jun 3, 2025 | |
| CYH Community Health Systems | Maintains: Underweight | $2 → $3.5 | $3.62 | -3.31% | 9 | May 29, 2025 | |
| HCA HCA Healthcare | Upgrades: Equal-Weight | $320 → $385 | $358.76 | +7.31% | 14 | May 29, 2025 | |
| THC Tenet Healthcare | Upgrades: Overweight | $150 → $195 | $171.15 | +13.94% | 13 | May 29, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $677 → $351 | $293.42 | +19.62% | 11 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $27 | $19.98 | +35.14% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.21 | +126.24% | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $76 → $84 | $64.21 | +30.82% | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $230 → $225 | $170.27 | +32.14% | 13 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $295 → $372 | $214.28 | +73.60% | 17 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $76 → $72 | $29.78 | +141.77% | 21 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $370 → $341 | $301.56 | +13.08% | 7 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $387 → $290 | $224.14 | +29.38% | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $7.90 | +89.87% | 3 | Apr 29, 2024 |
Elevance Health
Jul 15, 2025
Maintains: Overweight
Price Target: $478 → $400
Current: $339.17
Upside: +17.93%
Oscar Health
Jul 11, 2025
Downgrades: Underweight
Price Target: $16 → $10
Current: $14.72
Upside: -32.07%
The Pennant Group
Jun 3, 2025
Maintains: Equal-Weight
Price Target: $30 → $31
Current: $24.05
Upside: +28.90%
McKesson
Jun 3, 2025
Maintains: Equal-Weight
Price Target: $691 → $766
Current: $712.64
Upside: +7.49%
Cencora
Jun 3, 2025
Upgrades: Overweight
Price Target: $274 → $337
Current: $295.31
Upside: +14.12%
Cardinal Health
Jun 3, 2025
Upgrades: Overweight
Price Target: $136 → $179
Current: $161.34
Upside: +10.95%
Community Health Systems
May 29, 2025
Maintains: Underweight
Price Target: $2 → $3.5
Current: $3.62
Upside: -3.31%
HCA Healthcare
May 29, 2025
Upgrades: Equal-Weight
Price Target: $320 → $385
Current: $358.76
Upside: +7.31%
Tenet Healthcare
May 29, 2025
Upgrades: Overweight
Price Target: $150 → $195
Current: $171.15
Upside: +13.94%
UnitedHealth Group
May 14, 2025
Maintains: Overweight
Price Target: $677 → $351
Current: $293.42
Upside: +19.62%
May 13, 2025
Maintains: Overweight
Price Target: $25 → $27
Current: $19.98
Upside: +35.14%
May 13, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.21
Upside: +126.24%
May 6, 2025
Maintains: Overweight
Price Target: $76 → $84
Current: $64.21
Upside: +30.82%
Mar 10, 2025
Maintains: Overweight
Price Target: $230 → $225
Current: $170.27
Upside: +32.14%
Mar 5, 2025
Upgrades: Overweight
Price Target: $295 → $372
Current: $214.28
Upside: +73.60%
Feb 14, 2025
Maintains: Overweight
Price Target: $76 → $72
Current: $29.78
Upside: +141.77%
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $370 → $341
Current: $301.56
Upside: +13.08%
Nov 4, 2024
Maintains: Overweight
Price Target: $387 → $290
Current: $224.14
Upside: +29.38%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $7.90
Upside: +89.87%